{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:50:14Z","timestamp":1770231014082,"version":"3.49.0"},"reference-count":147,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2013,3,20]]},"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:p>Ulcerative colitis (UC) is a chronic idiopathic inflammatory disease of the gastrointestinal tract that affects the mucosal lining of the colon. Recent epidemiological data show that its incidence and prevalence are increasing in many parts of the world, in parallel with altered lifestyles, improved access to health, improved sanitation and industrialisation rates. Current therapeutic strategies for treating UC have only been moderately successful. Despite major recent advances in inflammatory bowel disease therapeutic resources, a considerable proportion of patients are still refractory to conventional treatment. Less than half of all patients achieve long-term remission, many require colectomy, and the disease still has a major impact on patients\u2019 lives. Moreover, recent data point to slightly raised mortality. While these outcomes could be partly improved by optimising current therapeutic strategies, they clearly highlight the need to develop new therapies. Currently, a number of promising and innovative therapeutic approaches are being explored, some of which will hopefully survive to reach the clinic. Until such a time arrives, it is important that a better understanding of the clinical particularities of the disease, an improved knowledge of the host-microbiome negative interactions and of the environmental factors beyond disease development is achieved to obtain the final and desired outcome: to provide better treatment and quality of life for patients with this disabling disease.<\/jats:p>","DOI":"10.1136\/gutjnl-2012-303959","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T12:44:40Z","timestamp":1381236280000},"page":"1642-1652","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["New therapeutic avenues in ulcerative colitis: thinking out of the box"],"prefix":"10.1136","volume":"62","clinical-trial-number":[{"clinical-trial-number":"nct00783718","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01465763","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01458951","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01470612","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01545908","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01560819","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01650038","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01650038","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01433471","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joana","family":"Torres","sequence":"first","affiliation":[{"name":"Gastroenterology Service, Surgery Department, Hospital Beatriz \u00c2ngelo, Loures, Portugal"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, Milan, Italy"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Colombel","sequence":"additional","affiliation":[{"name":"The Dr Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai New York, New York, USA"}]}],"member":"239","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"2025121303340684000_62.11.1642.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.001"},{"key":"2025121303340684000_62.11.1642.2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32832bfe05"},{"key":"2025121303340684000_62.11.1642.3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02252.x"},{"issue":"Suppl 8","key":"2025121303340684000_62.11.1642.4","first-page":"5","article-title":"Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan","volume":"30","author":"Kitahora","year":"1995","journal-title":"J Gastroenterol"},{"key":"2025121303340684000_62.11.1642.5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/00365528909091349","article-title":"Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany)","volume":"170","author":"Daiss","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2025121303340684000_62.11.1642.6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3748\/wjg.v10.i3.404","article-title":"Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977\u20132001","volume":"10","author":"Lakatos","year":"2004","journal-title":"World J Gastroenterol"},{"key":"2025121303340684000_62.11.1642.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2289-y"},{"key":"2025121303340684000_62.11.1642.8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.6641"},{"key":"2025121303340684000_62.11.1642.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.09.026"},{"key":"2025121303340684000_62.11.1642.10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.727"},{"key":"2025121303340684000_62.11.1642.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.09.002"},{"key":"2025121303340684000_62.11.1642.12","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802600961"},{"key":"2025121303340684000_62.11.1642.13","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21815"},{"key":"2025121303340684000_62.11.1642.14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.333"},{"key":"2025121303340684000_62.11.1642.15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300904"},{"key":"2025121303340684000_62.11.1642.16","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X10373176"},{"key":"2025121303340684000_62.11.1642.17","first-page":"CD006097","article-title":"Natalizumab for induction of remission in Crohn's disease","volume":"1","author":"MacDonald","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121303340684000_62.11.1642.18","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/S0016-5085(10)60667-1","article-title":"No increase in JC viremia, lymphocyte count, or circulating CD34+ hematopoietic progenitor cells after treatment with vedolizumab, a humanized monoclonal antibody to \u03b14\u03b27 integrin","volume":"138","author":"Parikh","year":"2010","journal-title":"Gastroenterology"},{"key":"2025121303340684000_62.11.1642.19","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/S0016-5085(12)60607-6","article-title":"Induction therapy for ulcerative colitis: results of GEMINI I, a randomized, placebo-controlled, double-blind, multicenter Phase 3 trial","volume":"142","author":"Feagan","year":"2012","journal-title":"Gastroenterology"},{"key":"2025121303340684000_62.11.1642.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(13)60342-6"},{"key":"2025121303340684000_62.11.1642.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(13)60534-6"},{"key":"2025121303340684000_62.11.1642.22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003668"},{"key":"2025121303340684000_62.11.1642.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112168"},{"key":"2025121303340684000_62.11.1642.24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis269"},{"key":"2025121303340684000_62.11.1642.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112072"},{"key":"2025121303340684000_62.11.1642.26","doi-asserted-by":"crossref","unstructured":"Mayer L Sandborn WJ Stepanov Y . Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study. Gut. Published Online First: 5 March 2013. doi: 10.1136\/gutjnl-2012-303424","DOI":"10.1136\/gutjnl-2012-303424"},{"key":"2025121303340684000_62.11.1642.27","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20993"},{"key":"2025121303340684000_62.11.1642.28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M704408200"},{"key":"2025121303340684000_62.11.1642.29","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410006233"},{"key":"2025121303340684000_62.11.1642.30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms11104149"},{"key":"2025121303340684000_62.11.1642.31","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.052316"},{"key":"2025121303340684000_62.11.1642.32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-9-200711060-00004"},{"key":"2025121303340684000_62.11.1642.33","doi-asserted-by":"crossref","first-page":"A-493","DOI":"10.1016\/S0016-5085(08)62303-3","article-title":"T1144 Results of a long-term follow-up treatment with delayed release phosphatidylcholine in chronic-active ulcerative colitis","volume":"134","author":"Karner","year":"2008","journal-title":"Gastroenterology"},{"key":"2025121303340684000_62.11.1642.34","doi-asserted-by":"crossref","first-page":"S-211","DOI":"10.1016\/S0016-5085(12)60790-2","article-title":"1157 Modified release phosphatidylcholine LT-02 in active ulcerative colitis\u2014a randomized, placebo-controlled multicentre study","volume":"142","author":"Karner","year":"2012","journal-title":"Gastroenterology"},{"key":"2025121303340684000_62.11.1642.35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302514a.153"},{"key":"2025121303340684000_62.11.1642.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00271-3"},{"key":"2025121303340684000_62.11.1642.37","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21322"},{"key":"2025121303340684000_62.11.1642.38","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.093484"},{"key":"2025121303340684000_62.11.1642.39","first-page":"3323","article-title":"An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis","volume":"96","author":"Lewis","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2025121303340684000_62.11.1642.40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.12.012"},{"key":"2025121303340684000_62.11.1642.41","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.114"},{"key":"2025121303340684000_62.11.1642.42","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.749"},{"key":"2025121303340684000_62.11.1642.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp078167"},{"key":"2025121303340684000_62.11.1642.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1008233"},{"key":"2025121303340684000_62.11.1642.45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041948"},{"key":"2025121303340684000_62.11.1642.46","doi-asserted-by":"publisher","DOI":"10.1021\/jm101360s"},{"key":"2025121303340684000_62.11.1642.47","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2008.28"},{"key":"2025121303340684000_62.11.1642.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050054"},{"key":"2025121303340684000_62.11.1642.49","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2199"},{"key":"2025121303340684000_62.11.1642.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.07.021"},{"key":"2025121303340684000_62.11.1642.51","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e32833a9ff1"},{"key":"2025121303340684000_62.11.1642.52","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.05.033"},{"key":"2025121303340684000_62.11.1642.53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0910283"},{"key":"2025121303340684000_62.11.1642.54","doi-asserted-by":"publisher","DOI":"10.1038\/nm849"},{"key":"2025121303340684000_62.11.1642.55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421086"},{"key":"2025121303340684000_62.11.1642.56","first-page":"13","article-title":"Healing with oxygen: a history of hyperbaric medicine","volume":"63","author":"Shah","year":"2000","journal-title":"Pharos Alpha Omega Alpha Honor Med Soc"},{"key":"2025121303340684000_62.11.1642.57","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200110000-00018"},{"key":"2025121303340684000_62.11.1642.58","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200209000-00021"},{"key":"2025121303340684000_62.11.1642.59","doi-asserted-by":"publisher","DOI":"10.1097\/01.SMJ.0000074507.31006.79"},{"key":"2025121303340684000_62.11.1642.60","first-page":"78","article-title":"Hyperbaric oxygenation as a part of the treatment of chronic ulcerohemorrhagic colitis","volume":"30","author":"Karkumov","year":"1991","journal-title":"Vutr Boles"},{"key":"2025121303340684000_62.11.1642.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)95043-7"},{"key":"2025121303340684000_62.11.1642.62","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00104"},{"key":"2025121303340684000_62.11.1642.63","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3282f2b0e8"},{"key":"2025121303340684000_62.11.1642.64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706625104"},{"key":"2025121303340684000_62.11.1642.65","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31827fec6d"},{"key":"2025121303340684000_62.11.1642.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.08.014"},{"key":"2025121303340684000_62.11.1642.67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1214816"},{"key":"2025121303340684000_62.11.1642.68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205037"},{"key":"2025121303340684000_62.11.1642.69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05220.x"},{"key":"2025121303340684000_62.11.1642.70","doi-asserted-by":"crossref","first-page":"S-540","DOI":"10.1016\/S0016-5085(12)62073-3","article-title":"Su1934 First reported complication of fecal microbiota transplant: ulcerative colitis flare after FMT for relapsing clostridium difficile infection","volume":"142","author":"Watson","year":"2012","journal-title":"Gastroenterology"},{"key":"2025121303340684000_62.11.1642.71","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21775"},{"key":"2025121303340684000_62.11.1642.72","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21067"},{"key":"2025121303340684000_62.11.1642.73","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.041749"},{"key":"2025121303340684000_62.11.1642.74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03805.x"},{"key":"2025121303340684000_62.11.1642.75","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21299"},{"key":"2025121303340684000_62.11.1642.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2012.10.021"},{"key":"2025121303340684000_62.11.1642.77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4557"},{"key":"2025121303340684000_62.11.1642.78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2414"},{"key":"2025121303340684000_62.11.1642.79","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1601-3_12"},{"key":"2025121303340684000_62.11.1642.80","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000160369.47671.a2"},{"key":"2025121303340684000_62.11.1642.81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07660.x"},{"key":"2025121303340684000_62.11.1642.82","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.01.005"},{"key":"2025121303340684000_62.11.1642.83","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.1.97"},{"key":"2025121303340684000_62.11.1642.84","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.4.1.1"},{"key":"2025121303340684000_62.11.1642.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2005.02.012"},{"key":"2025121303340684000_62.11.1642.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.028"},{"key":"2025121303340684000_62.11.1642.87","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.20196"},{"key":"2025121303340684000_62.11.1642.88","doi-asserted-by":"publisher","DOI":"10.1038\/nbt840"},{"key":"2025121303340684000_62.11.1642.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2007.09.007"},{"key":"2025121303340684000_62.11.1642.90","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.11.6.7946401"},{"key":"2025121303340684000_62.11.1642.91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s004180000163","article-title":"Localization of porcine trappin-2 (SKALP\/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry","volume":"114","author":"Suzuki","year":"2000","journal-title":"Histochem Cell Biol"},{"key":"2025121303340684000_62.11.1642.92","doi-asserted-by":"publisher","DOI":"10.1042\/BST0391450"},{"key":"2025121303340684000_62.11.1642.93","first-page":"686","article-title":"IBD: elafin-a potential IBD therapy","volume":"9","author":"Greenhill","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025121303340684000_62.11.1642.94","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421689"},{"key":"2025121303340684000_62.11.1642.95","doi-asserted-by":"crossref","first-page":"158ra44","DOI":"10.1126\/scitranslmed.3004212","article-title":"Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis","volume":"4","author":"Motta","year":"2012","journal-title":"Sci Transl Med"},{"key":"2025121303340684000_62.11.1642.96","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.12.050"},{"key":"2025121303340684000_62.11.1642.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.09.012"},{"key":"2025121303340684000_62.11.1642.98","unstructured":"Rawat DS Singh R . Plant-derived secondary metabolites as anticancer agents. Anticancer Agents Med Chem. Published Online First 7 February 2013. PMID: 23438829."},{"key":"2025121303340684000_62.11.1642.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.12.043"},{"key":"2025121303340684000_62.11.1642.100","first-page":"151","article-title":"HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1\/TH17 responses","volume":"19","author":"Michelsen","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2025121303340684000_62.11.1642.101","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.340"},{"key":"2025121303340684000_62.11.1642.102","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1900"},{"key":"2025121303340684000_62.11.1642.103","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001318"},{"key":"2025121303340684000_62.11.1642.104","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002648"},{"key":"2025121303340684000_62.11.1642.105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms12053303"},{"key":"2025121303340684000_62.11.1642.106","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2747rev"},{"key":"2025121303340684000_62.11.1642.107","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i23.2895"},{"key":"2025121303340684000_62.11.1642.108","doi-asserted-by":"publisher","DOI":"10.1038\/nmat2859"},{"key":"2025121303340684000_62.11.1642.109","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.67"},{"key":"2025121303340684000_62.11.1642.110","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.122192"},{"key":"2025121303340684000_62.11.1642.111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013160"},{"key":"2025121303340684000_62.11.1642.112","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.046615"},{"key":"2025121303340684000_62.11.1642.113","doi-asserted-by":"publisher","DOI":"10.1007\/BF02258391"},{"key":"2025121303340684000_62.11.1642.114","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.235408"},{"key":"2025121303340684000_62.11.1642.115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.01.006"},{"key":"2025121303340684000_62.11.1642.116","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.07.098"},{"key":"2025121303340684000_62.11.1642.117","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation\u2014a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"2025121303340684000_62.11.1642.118","doi-asserted-by":"crossref","first-page":"S-1","DOI":"10.1016\/S0016-5085(11)60002-4","article-title":"Early involvement of liver natural killer T cells in limiting colonic inflammation and application to disease treatment","volume":"140","author":"Chakass","year":"2011","journal-title":"Gastroenterology"},{"key":"2025121303340684000_62.11.1642.119","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302578"},{"key":"2025121303340684000_62.11.1642.120","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.03.015"},{"key":"2025121303340684000_62.11.1642.121","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.067389"},{"key":"2025121303340684000_62.11.1642.122","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80152-X"},{"key":"2025121303340684000_62.11.1642.123","doi-asserted-by":"publisher","DOI":"10.1517\/17425250802707342"},{"key":"2025121303340684000_62.11.1642.124","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbalip.2010.04.006","article-title":"Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease","volume":"1801","author":"Gadaleta","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2025121303340684000_62.11.1642.125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509592103"},{"key":"2025121303340684000_62.11.1642.126","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803978"},{"key":"2025121303340684000_62.11.1642.127","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.212159"},{"key":"2025121303340684000_62.11.1642.128","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbadis.2009.04.004","article-title":"Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages","volume":"1792","author":"Renga","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2025121303340684000_62.11.1642.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.04.005"},{"key":"2025121303340684000_62.11.1642.130","doi-asserted-by":"publisher","DOI":"10.1007\/BF01536701"},{"key":"2025121303340684000_62.11.1642.131","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200411000-00019"},{"key":"2025121303340684000_62.11.1642.132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03944.x"},{"key":"2025121303340684000_62.11.1642.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.12.010"},{"key":"2025121303340684000_62.11.1642.134","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21658"},{"key":"2025121303340684000_62.11.1642.135","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2007.12.009"},{"key":"2025121303340684000_62.11.1642.136","doi-asserted-by":"crossref","first-page":"S-883","DOI":"10.1016\/S0016-5085(12)63427-1","article-title":"Tu1940 cigarette smoke improves selectively colon and not small bowel inflammation through NKT cell activation","volume":"142","author":"Montbarbon","year":"2012","journal-title":"Gastroenterology"},{"key":"2025121303340684000_62.11.1642.137","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441104"},{"key":"2025121303340684000_62.11.1642.138","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.388"},{"key":"2025121303340684000_62.11.1642.139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04705.x"},{"key":"2025121303340684000_62.11.1642.140","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.3748\/wjg.v11.i31.4869","article-title":"Appendix is a priming site in the development of ulcerative colitis","volume":"11","author":"Matsushita","year":"2005","journal-title":"World J Gastroenterol"},{"key":"2025121303340684000_62.11.1642.141","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.2.707"},{"key":"2025121303340684000_62.11.1642.142","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.191320"},{"key":"2025121303340684000_62.11.1642.143","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300576"},{"key":"2025121303340684000_62.11.1642.144","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.192"},{"key":"2025121303340684000_62.11.1642.145","unstructured":"van der Logt EM Blokzijl T van der Meer R . Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme. J Nutr Biochem. pii: S0955-2863(12)00241-0."},{"key":"2025121303340684000_62.11.1642.146","doi-asserted-by":"crossref","unstructured":"Nagy-Szakal D Mir SA Ross MC . Monotonous diets protect against acute colitis in mice: epidemiologic and therapeutic implications. J Pediatr Gastroenterol Nutr. Published Online First: 18 October 2012. doi:10.1097\/MPG.0b013e3182769748","DOI":"10.1097\/MPG.0b013e3182769748"},{"key":"2025121303340684000_62.11.1642.147","doi-asserted-by":"publisher","DOI":"10.1038\/nature11225"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2012-303959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:34:15Z","timestamp":1765625655000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2012-303959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":147,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,10,8]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1136\/gutjnl-2012-303959"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2012-303959","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}